INS and Insulin resistance: Patients in the remission group had similar HOMA-IR values and higher IGI30 values at baseline and less increased HOMA-IR and more increased IGI30 values during the 1-year post-transplant period than those in the persistent diabetes group, suggesting that both insulin resistance and insulin secretory function were better in the remission group patients.